Anti-PD-1 approaches—important steps forward in metastatic melanoma

被引：9
|
作者：
Mina Razzak
机构：
来源：
Nature Reviews Clinical Oncology | 2013年 / 10卷 / 7期
关键词：
D O I：
10.1038/nrclinonc.2013.98
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：365 / 365
相关论文
共 50 条
  • [1] Resistance patterns to anti-PD-1 therapy in metastatic melanoma
    Ozgun, Alpaslan
    Sondak, Vernon K.
    Markowitz, Joseph
    CHINESE CLINICAL ONCOLOGY, 2016, 5 (06)
  • [2] Ipilimumab versus ipilimumab plus anti-PD-1 for metastatic melanoma
    Li, Mengqian
    LANCET ONCOLOGY, 2021, 22 (08): : E342 - E342
  • [3] Anti-PD-1 antibodies in metastatic uveal melanoma: a treatment option?
    Bender, Carolin
    Enk, Alexander
    Gutzmer, Ralf
    Hassel, Jessica C.
    CANCER MEDICINE, 2017, 6 (07): : 1581 - 1586
  • [4] Antiepidermis autoantibodies induced by anti-PD-1 therapy in metastatic melanoma
    Brunet-Possenti, Florence
    Mignot, Sabine
    Deschamps, Lydia
    Descamps, Vincent
    MELANOMA RESEARCH, 2016, 26 (05) : 540 - 543
  • [5] The cessation of anti-PD-1 antibodies of complete responders in metastatic melanoma
    Ladwa, Rahul
    Atkinson, Victoria
    MELANOMA RESEARCH, 2017, 27 (02) : 168 - 170
  • [6] Biomarker approaches for anti-PD-1 in melanoma: A meta-analysis
    Lu, S.
    Stein, J.
    Danilova, L.
    Hoyt, C.
    Taube, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S142 - S142
  • [7] Anti-PD-1 Therapy in Melanoma
    Moreno, Blanca Hornet
    Parisi, Giulia
    Robert, Lidia
    Ribas, Anton
    SEMINARS IN ONCOLOGY, 2015, 42 (03) : 466 - 473
  • [8] Modification of the Tumor Microenvironment Enhances Anti-PD-1 Immunotherapy in Metastatic Melanoma
    Shi, Guilan
    Scott, Megan
    Mangiamele, Cathryn G.
    Heller, Richard
    PHARMACEUTICS, 2022, 14 (11)
  • [9] Autoimmune hemolytic anemia induced by anti-PD-1 therapy in metastatic melanoma
    Kong, Benjamin Y.
    Micklethwaite, Kenneth P.
    Swaminathan, Sanjay
    Kefford, Richard F.
    Carlino, Matteo S.
    MELANOMA RESEARCH, 2016, 26 (02) : 202 - 204
  • [10] Ipilimumab versus ipilimumab plus anti-PD-1 for metastatic melanoma reply
    da Silva, Ines Pires
    Ahmed, Tasnia
    Reijers, Irene L. M.
    Warner, Allison Betof
    Patrinely, James Randall
    Serra-Bellver, Patricio
    Allayous, Clara
    Mangana, Joanna
    Zimmer, Lisa
    Trojaniello, Claudia
    Klein, Oliver
    Gerard, Camille L.
    Michielin, Olivier
    Haydon, Andrew
    Ascierto, Paolo A.
    Carlino, Matteo S.
    Lebbe, Celeste
    Lorigan, Paul
    Johnson, Douglas B.
    Sandhu, Shahneen
    Lo, Serigne N.
    Menzies, Alexander M.
    Long, Georgina, V
    LANCET ONCOLOGY, 2021, 22 (08): : E343 - E344
12345